NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Should You Invest in Axsome Therapeutics, Inc. (AXSM)? Before you invest in Axsome Therapeutics, Inc. (AXSM), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment ...

Investors considering a purchase of Axsome Therapeutics Inc (Symbol: AXSM) stock, but cautious about paying the going market price of $104.43/share, might benefit from considering selling puts ...

Axsome Therapeutics, Inc. has a 12 month low of $64.11 and a 12 month high of $139.13. Axsome Therapeutics ( NASDAQ:AXSM – Get Free Report ) last issued its quarterly earnings results on Tuesday ...

Axsome Therapeutics, Inc. has a 52 week low of $64.11 and a 52 week high of $139.13. The company has a quick ratio of 2.04, a current ratio of 2.11 and a debt-to-equity ratio of 3.22.

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

NEW YORK, April 8, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Axsome Therapeutics, Inc. (NASDAQ ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Axsome Therapeutics (NASDAQ:AXSM) Inc on Tuesday, setting a price... H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

All relevant comments and Axsome Therapeutics Inc share chat regarding the AXSM NASDAQ share news are listed here in the AXSM forum. View and contribute to the AXSM share chat. Discuss Axsome ...